ChemLex Raises $45M and Opens Self-Driving Drug Discovery Lab in Singapore

Dec 8, 2025
ChemLex has raised $45 million and established its global headquarters and self-driving laboratory in Singapore to accelerate AI-driven chemical discovery for pharmaceuticals.
ChemLex Raises $45M and Opens Self-Driving Drug Discovery Lab in Singapore

ChemLex has raised USD 45 million and established its global headquarters and self-driving laboratory in Singapore, announced in a press release. The funding round was led by Granite Asia and will support the hiring of additional engineers and chemists to expand the company’s research capabilities.

Founded in 2022, ChemLex develops AI-powered systems that accelerate chemical discovery in the pharmaceutical industry. Its autonomous chemistry platform operates continuously, conducting and analyzing experiments in real time to shorten the synthesis and optimization process from months to weeks.

The company also signed a memorandum of understanding with Singapore’s Experimental Drug Development Centre to advance small molecule drug discovery through automation. ChemLex’s move aligns with efforts by the Singapore Economic Development Board to strengthen the country’s life sciences and deep tech ecosystem.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.